Page last updated: 2024-10-18

dihydroxyphenylalanine and Congenital Adrenal Hyperplasia

dihydroxyphenylalanine has been researched along with Congenital Adrenal Hyperplasia in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spicáková, V1
Polácek, E1
Lacková, E1
Jodl, J1

Other Studies

1 other study available for dihydroxyphenylalanine and Congenital Adrenal Hyperplasia

ArticleYear
[Therapeutic complications in a case of adrenogenital syndrome with electrolyte imbalance].
    Casopis lekaru ceskych, 1967, Jun-23, Volume: 106, Issue:26

    Topics: Adrenal Hyperplasia, Congenital; Anorexia Nervosa; Child, Preschool; Dihydroxyphenylalanine; Female;

1967